Followers | 69 |
Posts | 23313 |
Boards Moderated | 4 |
Alias Born | 02/23/2009 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 14, 2019 11:17:56 AM
There were conversions just last february, as disclosed in the latest filing:
NOTE TO ISSUANCES:-
On February 2019 , shareholders representing an amount of 560,000 shares of Series “B” Convertible Preferred
Stock served Notices of Conversion to shares of Common Stock. This will increase in the amount of outstanding
Common Stock as was required to secure the majority shareholder vote to acquire the entire issued capital of
BioCann Pharma S.A.S. These conversions have not as yet been effected and it is envisaged that they will be in
and during May of 2019.
At a market price of 0.0001, 560 000 shares of Series B convert to 11.2 BILLION SHARES FOLKS or 5.6 BILLION if market price is 0.0002
And he dares to say NO CONVERSION ?
Welcome to the NEW TOXIC GNCP
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM